Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

Earnings Outlook For Zealand Pharma

Zealand Pharma (NASDAQ:ZEAL) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that Zealand Pharma will report an earnings per share (EPS) of $-0.94.

Expert Ratings for TPG

Expert Ratings for TPG

Within the last quarter, TPG (NASDAQ:TPG) has observed the following analyst ratings:

WAVE Life Sciences Earnings Preview

WAVE Life Sciences Earnings Preview

WAVE Life Sciences (NASDAQ:WVE) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that WAVE Life Sciences will report an earnings per share (EPS) of $-0.55.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Orchard Therapeutics Earnings Preview

Orchard Therapeutics (NASDAQ:ORTX) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that Orchard Therapeutics will report an earnings per share (EPS) of $-0.26.

OptiNose Earnings Preview

OptiNose (NASDAQ:OPTN) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that OptiNose will report an earnings per share (EPS) of $-0.27.

Earnings Outlook For SCYNEXIS

SCYNEXIS (NASDAQ:SCYX) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that SCYNEXIS will report an earnings per share (EPS) of $-0.75.

Preview: Virios Therapeutics's Earnings

Virios Therapeutics (NASDAQ:VIRI) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that Virios Therapeutics will report an earnings per share (EPS) of $-0.53.

inkl

Read news from The Economist, FT, and more,
with one subscription

What 4 Analyst Ratings Have To Say About AbCellera Biologics

What 4 Analyst Ratings Have To Say About AbCellera Biologics

Over the past 3 months, 4 analysts have published their opinion on AbCellera Biologics (NASDAQ:ABCL) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Earnings Outlook For Privia Health Group

Earnings Outlook For Privia Health Group

Privia Health Group (NASDAQ:PRVA) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that Privia Health Group will report an earnings per share (EPS) of $-0.04.

Earnings Outlook For Liquidia Technologies

Earnings Outlook For Liquidia Technologies

Liquidia Technologies (NASDAQ:LQDA) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that Liquidia Technologies will report an earnings per share (EPS) of $-0.20.

What 5 Analyst Ratings Have To Say About TechTarget

What 5 Analyst Ratings Have To Say About TechTarget

Over the past 3 months, 5 analysts have published their opinion on TechTarget (NASDAQ:TTGT) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Synlogic Earnings Preview

Synlogic Earnings Preview

Synlogic (NASDAQ:SYBX) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that Synlogic will report an earnings per share (EPS) of $-0.24.

Earnings Outlook For DarioHealth

Earnings Outlook For DarioHealth

DarioHealth (NASDAQ:DRIO) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that DarioHealth will report an earnings per share (EPS) of $-0.96.

Analyst Ratings for SoFi Technologies

Analyst Ratings for SoFi Technologies

Within the last quarter, SoFi Technologies (NASDAQ:SOFI) has observed the following analyst ratings:

Get all your
news in one place.

100's of premium titles.
One news app.

Analyst Ratings for Playtika Holding

Over the past 3 months, 5 analysts have published their opinion on Playtika Holding (NASDAQ:PLTK) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Ominous Death Cross Forms On Fortinet's Chart

If history is any guide, there may be trouble ahead for shares of Fortinet (NASDAQ:FTNT). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

This Foreboding Sign Looms Over Fox's Chart

If history is any guide, there may be trouble ahead for shares of Fox (NASDAQ:FOX). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

5 Value Stocks To Watch In The Industrials Sector

What are Value Stocks?

Get all your
news in one place.

100's of premium titles.
One news app.

Compass Pathways Reports Q1 Financial Results, With Increased R&D Expenses Compared To 2021

Compass Pathways (NASDAQ: CMPS) announced its financial results for the first quarter of 2022, which ended March 31. Q1 Results For the first three months of the year, net loss was $21.2 million, or $0.50 loss per share. For comparison, net loss in the same period of 2021 was $12.7 million…

First Patient Dosed in Phase 2 Study of Intercept's OCA and Bezafibrate Combination for Primary Biliary Cholangitis

Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) dosed first patient in a Phase 2 study evaluating a fixed-dose combination of obeticholic acid (OCA) and bezafibrate (BZF) for the treatment of patients with primary biliary cholangitis (PBC).

StoneCastle Financial's Earnings Outlook

StoneCastle Financial (NASDAQ:BANX) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that StoneCastle Financial will report an earnings per share (EPS) of $0.46.

Earnings Preview For Biolase

Biolase (NASDAQ:BIOL) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that Biolase will report an earnings per share (EPS) of $-0.68.

Expert Ratings for IAC/InterActive

Analysts have provided the following ratings for IAC/InterActive (NASDAQ:IAC) within the last quarter:

Earnings Preview: Dare Bioscience

Dare Bioscience (NASDAQ:DARE) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that Dare Bioscience will report an earnings per share (EPS) of $-0.14.

What 10 Analyst Ratings Have To Say About Dentsply Sirona

Analysts have provided the following ratings for Dentsply Sirona (NASDAQ:XRAY) within the last quarter:

1 … 534 535 536 537

Organisations

SoFi Technologies

Compass Pathways

Dentsply Sirona

WAVE Life Sciences

Intercept Pharmaceuticals

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play